NCT06216262

Brief Summary

Dentin sensitivity is one of the most common problems in society and affects the quality of life related to oral health. Agents such as toothpaste, mouthwash, and dental cream are home-type desensitizing agents used as the first step in the treatment of dentin hypersensitivity. A total of 180 individuals with dentin sensitivity will be included in the study and the individuals will be randomly divided into 6 groups. Individuals in the 1st Group will be given arginine-containing toothpaste, individuals in the 2nd Group will be given novamin-containing toothpaste, individuals in the 3rd Group will be given propolis-containing toothpaste, individuals in the 4th Group will be given casein phosphopeptide amorphous calcium phosphate-containing dental cream, and individuals in the 5th Group will be given mouthwash containing potassium nitrate. Classic toothpaste with 1450 ppm fluoride will be distributed to individuals in the control group, which is the 6th group. The Dentin Hypersensitivity Experience Questionnaire (DHEQ-15), consisting of 15 questions, will be used to evaluate dentin sensitivity. Visual Analogue Scale (VAS) will be used to determine the individual's pain score in dentin sensitivity, and the individual will be asked to score the intensity of pain experienced between 0-10 points. Finally, in the evaluation of dentin sensitivity, a single dentist will apply air to the cervix of the tooth from a distance of 1 cm for 1 second, and the Schiff Sensitivity Scale score will be determined through clinical examination. A score between 0 and 3 will be determined by the dentist according to the patient's response to the air stimulus. The effectiveness of the home-use desensitizing agents used in the treatment of dentin hypersensitivity was evaluated with DHEQ-15, VAS and Schiff Sensitivity Scale; Baseline, 4th and 8th week scores will be compared.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 26, 2023

Completed
27 days until next milestone

First Posted

Study publicly available on registry

January 22, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

March 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 23, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 23, 2024

Completed
Last Updated

August 26, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

December 26, 2023

Last Update Submit

August 23, 2024

Conditions

Keywords

ArginineNovaminPropolis

Outcome Measures

Primary Outcomes (3)

  • Dentine Hypersensitivity Experience Questionnaire-15 (DHEQ-15)

    Dentin Hypersensitivity Experience Questionnaire-15 (DHEQ-15) is a 7-point Likert scale form consisting of 15 questions used to evaluate dentin sensitivity, with answers ranging from 'strongly agree' to 'strongly disagree'.

    for 8 weeks (initially, 4 weeks and 8 weeks)

  • Visual Analogue Scale (VAS)

    VAS is a scale in which the individual evaluates the pain level between 0 (no hurt) and 10 (hurts worst).

    for 8 weeks (initially, 4 weeks and 8 weeks)

  • Schiff Sensitivity Scale

    In the evaluation of dentin hypersensitivity, a single dentist will apply air to the cervix of the tooth from a distance of 1 cm for 1 second during a clinical examination and the Schiff Sensitivity Scale score will be determined. 0: subject does not respond to air stimulus 1. subject responds to air stimulus but does not request discontinuaiton of stimulus 2. subject responds to air stimulus and requests discontinuaiton or moves from stimulus 3. subject responds to the air stimulus, considers stimulus to be painful and requests discontinuaiton of the stimulus

    for 8 weeks (initially, 4 weeks and 8 weeks)

Study Arms (6)

Control group

ACTIVE COMPARATOR

1450 ppm fluoride toothpaste

Other: Control group

Arginine

ACTIVE COMPARATOR

toothpaste containing arginine

Other: Arginine

Novamin

ACTIVE COMPARATOR

toothpaste containing novamin

Other: Novamin

Propolis

ACTIVE COMPARATOR

toothpaste containing propolis

Other: Propolis

Casein Phosphopeptide Amorphous Calcium Phosphate

ACTIVE COMPARATOR

Dental cream containing casein phosphopeptide amorphous calcium phosphate

Other: Control groupOther: Casein Phosphopeptide Amorphous Calcium Phosphate

Potassium Nitrate

ACTIVE COMPARATOR

mouthwash containing potassium nitrate

Other: Control groupOther: Potassium Nitrate

Interventions

Brushing teeth twice a day for 8 weeks

Casein Phosphopeptide Amorphous Calcium PhosphateControl groupPotassium Nitrate

Brushing teeth twice a day for 8 weeks

Arginine
NovaminOTHER

Brushing teeth twice a day for 8 weeks

Novamin

Brushing teeth twice a day for 8 weeks

Propolis

Following the procedure in the control group, it is applied to the tooth surface once a day for 3 minutes before going to bed at night for 8 weeks

Casein Phosphopeptide Amorphous Calcium Phosphate

Following the procedure in the control group, mouthwash twice a day in the morning and evening for 8 weeks

Potassium Nitrate

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Between 18-70 years old
  • General health condition is good
  • Individuals with sensitivity in 2 or more non-adjacent teeth

You may not qualify if:

  • Pregnant or breastfeeding women
  • Advanced periodontal diseases
  • Chronic diseases that may affect the study results
  • Major oral pathologies
  • Use of anticonvulsant, antihistamine, antidepressant, sedative, tranquilizer medication
  • Use of desensitizing paste in the last 3 months
  • Individuals who have been treated for periodontal disease in the last 12 months

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Canakkale Onsekiz Mart University Faculty of Dentistry

Çanakkale, Turkey (Türkiye)

Location

Related Publications (4)

  • Mason S, Burnett GR, Patel N, Patil A, Maclure R. Impact of toothpaste on oral health-related quality of life in people with dentine hypersensitivity. BMC Oral Health. 2019 Oct 22;19(1):226. doi: 10.1186/s12903-019-0919-x.

    PMID: 31640741BACKGROUND
  • Baker SR, Gibson BJ, Sufi F, Barlow A, Robinson PG. The Dentine Hypersensitivity Experience Questionnaire: a longitudinal validation study. J Clin Periodontol. 2014 Jan;41(1):52-9. doi: 10.1111/jcpe.12181. Epub 2013 Nov 6.

    PMID: 24117696BACKGROUND
  • Basaran S, Celik C. Turkish Adaptation of Dentine Hypersensitivity Experience Questionnaire (DHEQ). Community Dent Health. 2018 Mar 1;35(1):47-51. doi: 10.1922/CDH_4151Basaran05.

    PMID: 29369544BACKGROUND
  • Ayan G, Msmall i, Ukrainianssmall i, Ukrainianllsmall i, Ukrainian T, Buldur M. Home-use agents in the treatment of dentin hypersensitivity: clinical effectiveness evaluation with different measurement methods. Clin Oral Investig. 2025 Jan 15;29(1):63. doi: 10.1007/s00784-025-06155-1.

MeSH Terms

Conditions

Dentin Sensitivity

Interventions

Control GroupsArginineNovaMinPropoliscasein phosphopeptide-amorphous calcium phosphate nanocomplexpotassium nitrate

Condition Hierarchy (Ancestors)

Tooth DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethodsAmino Acids, BasicAmino AcidsAmino Acids, Peptides, and ProteinsAmino Acids, DiaminoAmino Acids, EssentialResins, PlantBiopolymersPolymersMacromolecular SubstancesPlant ExudatesBiological ProductsComplex Mixtures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

December 26, 2023

First Posted

January 22, 2024

Study Start

March 1, 2024

Primary Completion

August 23, 2024

Study Completion

August 23, 2024

Last Updated

August 26, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations